Bruno Brochet

INSERM U1219

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Alessandra Solari

Head, MD

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

View details

Fredrik Piehl

Karolinska Institutet

SWEDEN

View details

Luis Brieva Ruiz

Head of the department

Hospital Universitari Arnau de Vilanova

SPAIN

View details

francesco patti

Professore Associato di Neurologia SSD Med 26

University of Catania

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bruno Brochet

Research Interests

Explore related searches

Contact this professor

Articles (11)

Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis

Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study

Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment

Altered functional brain states predict cognitive decline 5 years after a clinically isolated syndrome

Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries

Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype

Cognitive Rehabilitation in Multiple Sclerosis in the Period from 2013 and 2021: A Narrative Review

BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS

Structural constraints of functional connectivity drive cognitive impairment in the early stages of multiple sclerosis

Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)

Double‐blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate‐to‐severe relapses of multiple sclerosis

Collaborators (4)

Alessandra Solari

Fredrik Piehl

Luis Brieva Ruiz

francesco patti

Make your next move.